FDA Approves Wegovy Pill: The First Oral GLP-1 for Weight Loss Is Here
Novo Nordisk's Wegovy pill wins FDA approval as the first oral GLP-1 medication for weight loss. The starting dose will cost $149/month beginning January 2025.
TRENDING TOPICS
1312 articles found for "investing"
Novo Nordisk's Wegovy pill wins FDA approval as the first oral GLP-1 medication for weight loss. The starting dose will cost $149/month beginning January 2025.
The U.S. seized a second oil tanker off Venezuela as Trump's blockade intensifies. Russia and China back Caracas at an emergency UN Security Council meeting.
The S&P 500 rose for a third consecutive day, approaching its all-time high as AI stocks recovered and investors positioned for 2026. Markets close early Wednesday for Christmas.
Nvidia aims to begin shipping H200 AI chips to China by mid-February after Trump granted approval in exchange for a 25% surcharge. Alibaba and ByteDance are ready to buy.
Bitcoin dropped below $88,000 as traders brace for the largest single-day options expiry in crypto history. The Fear & Greed Index signals extreme fear.
The U.S. economy grew at a 4.3% annual rate in the third quarter, crushing expectations and marking the fastest expansion in two years. Here's what it means for investors.
Markets face a holiday-shortened week with light volumes and limited catalysts. Here's what investors should watch as 2025 trading winds down.
Citigroup sets base case Bitcoin target at $143,000 for December 2026, citing ETF demand and regulatory tailwinds. Bull case reaches $189,000.
Vanguard reverses its longtime crypto ban, opening Bitcoin and Ethereum ETF access to its 50 million brokerage customers. The move signals mainstream adoption.
Nearly $300 billion in Bitcoin that was dormant for over a year has re-entered circulation. CryptoQuant data shows the heaviest long-term holder selling in five years.
Nvidia tells Chinese clients it will begin H200 chip shipments before Lunar New Year, with initial orders of up to 80,000 chips for Alibaba, ByteDance.
Cleveland Fed President Beth Hammack signals the Fed may hold rates steady for months ahead. Markets now pricing 75% chance of no January move.